Regulatory
Key facts
FDA issued a discussion paper on GenAI-enabled medical devices
Key facts
FDA is seeking feedback from interested parties on the regulation of GenAI-enabled medical devices
Key facts
The discussion paper concerns risk assessment, premarket evaluation, and postmarket monitoring
Atlas Watchline
The FDA has issued a discussion paper on generative AI-enabled medical devices and is seeking public…